Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Cell Point (India)'s Sloan Ratio for the quarter that ended in Mar. 2024 was 29.40%.
Warning Sign:
When sloan ratio (29.4)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.
As of Mar. 2024, Cell Point (India) has a Sloan Ratio of 29.40%, indicating earnings are more likely to be made up of accruals.
Cell Point (India) Sloan Ratio % Historical Data
The historical data trend for Cell Point (India)'s Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cell Point (India)'s Sloan Ratio %
For the Specialty Retail subindustry, Cell Point (India)'s Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Point (India)'s Sloan Ratio % Distribution in the Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Cell Point (India)'s Sloan Ratio % falls into.
Cell Point (India) Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Cell Point (India)'s Sloan Ratio for the fiscal year that ended in Mar. 2024 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
Cell Point (India)'s Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was 16.878 (Sep. 2023 ) + 0.055 (Mar. 2024 ) = ₹17 Mil.
Cell Point (India)'s Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was -165.995 (Sep. 2023 ) + 94.196 (Mar. 2024 ) = ₹-72 Mil.
Cell Point (India)'s Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was -118.969 (Sep. 2023 ) + -186.551 (Mar. 2024 ) = ₹-306 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Point (India) (NSE:CELLPOINT) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2024, Cell Point (India) has a Sloan Ratio of 29.40%, indicating earnings are more likely to be made up of accruals.
Cell Point (India) Sloan Ratio % Related Terms
Thank you for viewing the detailed overview of Cell Point (India)'s Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.
Cell Point (India) (NSE:CELLPOINT) Business Description
Cell Point (India) Ltd is engaged in multi-brand retail selling of Smart Phones, tablets, mobile accessories, and mobile-related products and allied accessories of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, GIONEE, VIVO, etc. It is also engaged in retail selling of some of the consumer durable electronics goods, specifically, smart televisions of various brands such as Xiaomi, Realme, and One Plus. The company also provides payment options such as credit/EMI facilities including UPI, vouchers, & pay-on-delivery to its customers for buying its products for which the company has tied up with major leading credit houses.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:CELLPOINT has been successfully added to your